,0
Name,"LYELL IMMUNOPHARMA, INC."
Currency,USD
Sector,Healthcare
Industry,Biotechnology
Country,US
IPO,"Jun 17, 2021"
Insider Percentage,16.24%
Institution Percentage,53.77%
